U.S Pacemaker Market – By Type , By Technology , By Implantability , By Application , By End User Opportunity Analysis & Industry Forecast, 2024-2030

U.S Pacemaker Market Overview:

U.S Pacemaker Market size is estimated to reach US $3.4 billion by 2030, growing at a CAGR of 4.9% during the forecast period 2024-2030. Pacemakers are devices that can be inserted into the human body to support the heart's electrical system, usually by surgery. They can prevent disorders that could disturb or endanger life and settle irregular heartbeats. The U.S pacemaker market is driven by the factors such as increasing prevalence of cardiovascular diseases, Technological advancements in pacemaker technology and design, rise in demand for minimally invasive procedures and development of healthcare infrastructure and increased spending on healthcare sector. Additionally, advancements such as wireless remote monitoring in pacemakers are driving the growth of the U.S Pacemaker market.  One of the most significant trends in the pacemaker innovations is the development of leadless pacemakers. These pacemakers eliminate the risks by incorporating the pulse generator and electrodes into a single, small device. Leadless pacemakers are installed by a catheter through the femoral vein, reducing surgical trauma. These devices have showed exceptional performance and safety profiles, with a lower risk of infection and problems associated with leads. For instance, In June 2024, a cardiac electrophysiologist at Stanford Health Care successfully implanted the institution’s first leadless dual chamber pacemaker, Abbott Aveir DR. This treatment is designed for patients who need pacing in two chambers of the heart. It includes two devices, one that is implanted in the right atrium (top chamber) and the other in the right ventricle (bottom chamber). Additionally, Rate-responsive pacing is a further significant advancement in pacemaker technology. Depending on the patient's physiological factors or degree of activity, it can modify the pacing rate. To identify changes in the patient's activity or metabolic requirements, these devices employ a variety of sensors, including impedance sensors, minute ventilation sensors, and accelerometers. Patients with chronotropic incompetence, in which the heart is unable to suitably increase its rate during physical exercise, have found it especially helpful. Such trends are propelling the growth of the U.S pacemaker market significantly. 

U.S Pacemaker Market - Report Coverage:

The “U.S Pacemaker Market Report - Forecast (2024-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the U.S Pacemaker Market.

COVID-19 / Ukraine Crisis - Impact Analysis:  

• The U.S. Pacemaker Market was impacted significantly by the COVID 19 pandemic. Early in the pandemic, hospitals postponed elective surgeries, including pacemaker implantations, to prioritize COVID-19 patients and conserve resources. As a result several surgeries that were not considered critical were postponed to minimize the infection rate which affected the pacemaker market. 
• The Russia-Ukraine crisis had a complex impact on the US pacemaker market. Crucial raw materials like titanium, palladium, and neon that are needed in the production of pacemakers have had their supply lines interrupted by the crisis. Potential pacemaker shortages and higher production costs resulted from these interruptions. 

Key Takeaways

MRI Compatible Pacemaker Dominated the Market 

The MRI compatible pacemaker segment dominated the U.S Pacemaker market in 2023. Manufacturers of pacemakers have created devices that are compatible with MRI under specific circumstances after recognizing the growing issues caused by pacemaker wearers need for MRI. For instance, in December 2024, Royal Philips and Mayo Clinic announced a research collaboration to advance cardiac MRI applications. The partnership aims to use AI technology from both organizations to shorten complex MRI exams, streamline radiologist workflows, and reduce scan times. This initiative seeks to alleviate the burden on healthcare professionals and address the shortage of trained staff, enabling even less experienced radiographers to perform advanced cardiac MRI procedures effectively. Additionally, according to Philips USA, around 3.9% of the U.S. population are currently fitted with a metallic orthopedic or cardiac implant, many of whom are currently denied an MRI scan due to safety concerns. It also has been estimated that 50% to 75% of patients who are fitted with a cardiac implantable electronic device are expected to benefit from a lower-field-strength solution at some point in their patient journey. Such factors are propelling the growth of the U.S Pacemaker market.  

Implantable Pacemaker the Largest Segment

Implantable pacemakers are largest segment in the U.S Pacemaker market, in terms of implantability. Continuous improvements in implantation pacemaker technology have produced more compact, dependable devices with enhanced features such as remote monitoring and MRI compatibility. For instance, in March 2024, MicroPort CRM announced the first U.S. implantation of its ALIZEA Bluetooth pacemaker system at PIH Health Downey Hospital in California. The procedure introduced a system combining the ALIZEA pacemaker generator, VEGA pacing leads, a SmartTouch XT tablet-based programmer, and the SmartView Connect Bluetooth monitor. This advanced system offers remote monitoring capabilities equivalent to in-person follow-ups, enhancing heart rhythm management with cutting-edge technology. Additionally, ALIZEA protects patients by automatically switching to pre-programmed settings when a patient undergoes an MRI scan. The pacemaker may be pre-programmed up to 10 days in advance of the MRI scan. Such continuous technological advancements are fueling the growth of the U.S Pacemaker market. 

Increasing Prevalence of Cardiovascular Diseases

Increasing prevalence of cardiovascular diseases are driving the growth of the U.S pacemaker market. For instance, according to data from National Heart, Lung, and Blood Institute, Cardiac arrhythmias affect about 5% of the U.S. population and are a major cause of morbidity and mortality, resulting in more than 250,000 deaths annually in the United States. As arrhythmias may present without symptoms and can reoccur or intensify suddenly, they may be undiagnosed in patients. When the heart’s natural pacemaker is defective, the heartbeat may be too fast, too slow or irregular. Rhythm problems also can occur because of a blockage or abnormality of your heart’s electrical pathways. An artificial pacemaker replaces the heart’s defective natural pacemaker functions. Most pacemakers work only when they’re needed (demand pacemakers). Additionally, Pacemakers may also be used to help heart chambers beat in sync if the heart isn’t pumping enough blood to body. Such factors are propelling the growth of the U.S pacemaker market.  

Technological Advancements in Treatments 

Technological advancements in cardiovascular disease treatments are driving the growth of the U.S Pacemaker market significantly. For instance, A new tool to help calculate cardiovascular risk was invented by American Heart Association. The PREVENT risk calculator is a new tool developed by volunteer science experts working with the American Heart Association to help people better understand their risk for developing heart disease, stroke or heart failure. It calculates 10- and 30-year total cardiovascular disease risk using heart, kidney and metabolic health measures such as cholesterol, blood pressure, blood glucose, weight and age. The tool was validated using data from more than 6 million U.S. adults whose average age was 53 years old. Over an average 4.8 years of follow-up, PREVENT accurately and precisely predicted risk for cardiovascular disease and its many subtypes in a large, diverse and contemporary sample of U.S. adults. PREVENT enables early identification of high-risk individuals by properly predicting their risk of cardiovascular disease. This makes it possible to take preventative measures, including as changing one's lifestyle and, if required, getting a pacemaker installed.  

Cybersecurity Risks  

One of the key challenges in the U.S Pacemaker market is the vulnerability to cyber-attacks. Cardiac implantable electronic devices (CIEDs) include bradycardia pacemakers, defibrillators, and cardiac resynchronization therapy devices. Remote monitoring of CIED uses telemetry and IP connectivity to transmit data from devices to the cloud and eventually to hospitals/clinics monitoring them. Although Internet of Things (IOT) dependence is growing, but the benefits of connectivity and data transfer come at a cost: hacking can lead to computer malfunctions, misuse of stolen data or medical extortion. For instance, In July 2024, Alabama Cardiovascular Group filed a report with HHS confirming that more than 280,000 individuals were affected by a healthcare data breach. The affected information varied by person but could have included names, phone numbers, demographic information, Social Security numbers, email addresses, usernames and passwords, and health insurance claims information. For some individuals, passport or driver's license numbers, credit card information and bank account information might have been involved in the breach. Thus, ensuring the security of these devices can be a critical challenge for manufacturers. 

For more details on this report - Request for Sample

Key Market Players: 

Product/Service launches, approvals, patents and events, acquisitions, partnerships and collaborations are key strategies adopted by players in the U.S Pacemaker Market. The top 10 companies in the U.S Pacemaker Market are:

1. Medtronic 
2. Abbott 
3. Boston Scientific Corporation 
4. Biotronik 
5. MicroPort Scientific Corporation  
6. OSCOR Inc 
7. LivaNova, Inc. 
8. Teleflex Incorporated 
9. St. Jude Medical
10. Sorin Medical Group

Scope of Report: 

For more Lifesciences and Healthcare Market reports, please click here